Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Aspen Aerogels (ASPN) EBT (2016 - 2025)

Aspen Aerogels (ASPN) has disclosed EBT for 13 consecutive years, with -$5.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT rose 54.81% year-over-year to -$5.7 million, compared with a TTM value of -$303.0 million through Sep 2025, down 9055.39%, and an annual FY2024 reading of $15.1 million, up 132.94% over the prior year.
  • EBT was -$5.7 million for Q3 2025 at Aspen Aerogels, up from -$8.2 million in the prior quarter.
  • Across five years, EBT topped out at $17.7 million in Q2 2024 and bottomed at -$300.2 million in Q1 2025.
  • Average EBT over 5 years is -$24.7 million, with a median of -$11.6 million recorded in 2021.
  • The sharpest move saw EBT surged 2255.49% in 2024, then plummeted 27719.56% in 2025.
  • Year by year, EBT stood at -$16.4 million in 2021, then skyrocketed by 41.24% to -$9.6 million in 2022, then surged by 94.6% to -$519000.0 in 2023, then soared by 2255.49% to $11.2 million in 2024, then crashed by 151.31% to -$5.7 million in 2025.
  • Business Quant data shows EBT for ASPN at -$5.7 million in Q3 2025, -$8.2 million in Q2 2025, and -$300.2 million in Q1 2025.